British Columbia is expanding use of pneumococcal conjugate 13-valent vaccine (PCV13, Prev-nar 13) to HIV-infected adults starting in April 2015. Since June 2010, the vaccine has been in use for... Read More
British Columbia is expanding use of pneumococcal conjugate 13-valent vaccine (PCV13, Prev-nar 13) to HIV-infected adults starting in April 2015. Since June 2010, the vaccine has been in use for... Read More

Context Hepatitis C virus (HCV) infection is an important cause of progressive liver disease. It is spread through blood-to-blood contact and seldom produces symptoms at the time of infection. Three... Read More

Since whole-cell pertussis vaccine was replaced with acellular pertussis (aP) vaccine in BC in 1997, systemic adverse events in infants such as febrile seizures and hypotonic hyporesponsive episodes... Read More

The BC Drug and Poison Information Centre handled 95 cases of bupropion (Wellbutrin, Zyban) exposure in 2013. Eighty-one cases involved adults, with 22 therapeutic errors, 47 cases of suspected... Read More

Carbapenemase-producing organisms (CPOs) are bacteria with an acquired genetic resistance to broad-spectrum antibiotics, including the carbapenem family of drugs. Provincial data from as early as... Read More